89bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.56 | -$0.56 | -$0.56 |
| Q2 2024 | 5 | -$0.70 | -$0.59 | -$0.62 |
| Q3 2024 | 3 | -$0.57 | -$0.57 | -$0.57 |
| Q1 2025 | 4 | -$0.65 | -$0.65 | -$0.65 |
| Q2 2025 | 4 | -$0.66 | -$0.66 | -$0.66 |
| Q3 2025 | 4 | -$0.65 | -$0.65 | -$0.65 |
| Q4 2025 | 4 | -$0.68 | -$0.68 | -$0.68 |
89bio, Inc. Earnings Date And Information
89bio, Inc. last posted its earnings results on Monday, August 5th, 2024. The company reported $-0.48 earnings per share for the quarter, topping analysts' consensus estimates of $-0.56 by $0.08. The company had revenue of 0 for the quarter and had revenue of 0 for the year. 89bio, Inc. has generated $-2 earnings per share over the last year ($-2 diluted earnings per share) and currently has a price-to-earnings ratio of -5.28. 89bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
89bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2024 | Q2 2024 | -$0.56 | -$0.48 | 0.08 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.48 | -$0.54 | -0.06 | $0 | |
| 03/01/2024 | Q4 2023 | -$0.50 | $234,000 | |||
| 11/09/2023 | Q3 2023 | -$0.45 | $0 | |||
| 08/09/2023 | Q2 2023 | -$0.41 | -$0.52 | -0.11 | $0 | |
| 05/05/2023 | Q1 2023 | -$1.58 | $0 | |||
| 03/14/2023 | Q4 2022 | -$0.48 | $0 | |||
| 11/10/2022 | Q3 2022 | -$0.89 | -$0.57 | 0.32 | $0 | |
| 08/11/2022 | Q2 2022 | -$1.04 | -$1.25 | -0.21 | $0 | |
| 05/12/2022 | Q1 2022 | -$1.26 | $0 | |||
| 03/24/2022 | Q4 2021 | -$1.30 | $0 | |||
| 11/12/2021 | Q3 2021 | -$1.41 | $0 | |||
| 08/12/2021 | Q2 2021 | -$1.03 | $0 | |||
| 05/13/2021 | Q1 2021 | -$0.74 | $0 | |||
| 03/24/2021 | Q4 2020 | -$0.63 | $0 | |||
| 11/12/2020 | Q3 2020 | -$0.87 | $0 | |||
| 08/13/2020 | Q2 2020 | -$0.85 | -$0.85 | 0 | $0 | |
| 05/13/2020 | Q1 2020 | -$0.92 | -$0.76 | 0.16 | $0 | |
| 03/18/2020 | Q4 2019 | -$2.58 | $0 | |||
| 12/18/2019 | Q3 2019 | -$1.20 | -$1.55 | -0.35 | $0 |
89bio, Inc. Earnings: Frequently Asked Questions
-
When is 89bio, Inc.'s earnings date?
89bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
Did 89bio, Inc. beat their earnings estimates last quarter?
In the previous quarter, 89bio, Inc. (:ETNB) reported $-0.48 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.56 by $0.08.
-
How can I listen to 89bio, Inc.'s earnings conference call?
The conference call for 89bio, Inc.'s latest earnings report can be listened to online.
-
How can I read 89bio, Inc.'s conference call transcript?
The conference call transcript for 89bio, Inc.'s latest earnings report can be read online.
-
How much profit does 89bio, Inc. generate each year?
89bio, Inc. (:ETNB) has a recorded net income of $0. 89bio, Inc. has generated $-2 earnings per share over the last four quarters.
-
What is 89bio, Inc.'s price-to-earnings ratio?
89bio, Inc. (:ETNB) has a price-to-earnings ratio of -5.28 and price/earnings-to-growth ratio is -2.65.
